{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:58:03Z","timestamp":1789995483131,"version":"4.0.1"},"reference-count":107,"publisher":"National Institute for Health and Care Research","issue":"90","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["13\/05\/01"],"award-info":[{"award-number":["13\/05\/01"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"Background<\/jats:title>Dupuytren\u2019s disease is a slowly progressive condition of the hand, characterised by the formation of nodules in the palm that gradually develop into fibrotic cords. Contracture of the cords produces deformities of the fingers. Surgery is recommended for moderate and severe contractures, but complications and\/or recurrences are frequent. Collagenase clostridium histolyticum (CCH) has been developed as a minimally invasive alternative to surgery for some patients.<\/jats:p><\/jats:sec>Objectives<\/jats:title>To assess the clinical effectiveness and cost-effectiveness of collagenase as an alternative to surgery for adults with Dupuytren\u2019s contracture with a palpable cord.<\/jats:p><\/jats:sec>Data sources<\/jats:title>We searched all major electronic databases from 1990 to February 2014.<\/jats:p><\/jats:sec>Review methods<\/jats:title>Randomised controlled trials (RCTs), non-randomised comparative studies and observational studies involving collagenase and\/or surgical interventions were considered. Two reviewers independently extracted data and assessed risk of bias of included studies. A de novo Markov model was developed to assess cost-effectiveness of collagenase, percutaneous needle fasciotomy (PNF) and limited fasciectomy (LF). Results were reported as incremental cost per quality-adjusted life-year (QALY) gained. Deterministic and probabilistic sensitivity analyses were undertaken to investigate model and parameter uncertainty.<\/jats:p><\/jats:sec>Results<\/jats:title>Five RCTs comparing collagenase with placebo (493 participants), three RCTs comparing surgical techniques (334 participants), two non-randomised studies comparing collagenase and surgery (105 participants), five non-randomised comparative studies assessing various surgical procedures (3571 participants) and 15 collagenase case series (3154 participants) were included. Meta-analyses of RCTs assessing CCH versus placebo were performed. Joints randomised to collagenase were more likely to achieve clinical success. Collagenase-treated participants experienced significant reduction in contracture and an increased range of motion compared with placebo-treated participants. Participants treated with collagenase also experienced significantly more adverse events, most of which were mild or moderate. Four serious adverse events were observed in the collagenase group: two tendon ruptures, one pulley rupture and one complex regional pain syndrome. Two tendon ruptures were also reported in two collagenase case series. Non-randomised studies comparing collagenase with surgery produced variable results and were at high risk of bias. Serious adverse events across surgery studies were low. Recurrence rates ranged from 0% (at 90 days) to 100% (at 8 years) for collagenase and from 0% (at 2.7 years for fasciectomy) to 85% (at 5 years for PNF) for surgery. The results of the de novo economic analysis show that PNF was the cheapest treatment option, whereas LF generated the greatest QALY gains. Collagenase was more costly and generated fewer QALYs compared with LF. LF was \u00a31199 more costly and generated an additional 0.11 QALYs in comparison with PNF. The incremental cost-effectiveness ratio was \u00a310,871 per QALY gained. Two subgroup analyses were conducted for a population of patients with moderate and severe disease and up to two joints affected. In both subgroup analyses, collagenase remained dominated.<\/jats:p><\/jats:sec>Limitations<\/jats:title>The main limitation of the review was the lack of head-to-head RCTs comparing collagenase with surgery and the limited evidence base for estimating the effects of specific surgical procedures (fasciectomy and PNF). Substantial differences across studies further limited the comparability of available evidence. The economic model was derived from a naive indirect comparison and was hindered by a lack of suitable data. In addition, there was considerable uncertainty about the appropriateness of many assumptions and parameters used in the model.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>Collagenase was significantly better than placebo. There was no evidence that collagenase was clinically better or worse than surgical treatments. LF was the most cost-effective choice to treat moderate to severe contractures, whereas collagenase was not. However, the results of the cost\u2013utility analysis are based on a naive indirect comparison of clinical effectiveness, and a RCT is required to confirm or refute these findings.<\/jats:p><\/jats:sec>Study registration<\/jats:title>This study is registered as PROSPERO CRD42013006248.<\/jats:p><\/jats:sec>Funding<\/jats:title>The National Institute for Health Research Health Technology Assessment programme.<\/jats:p><\/jats:sec>","DOI":"10.3310\/hta19900","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T11:38:13Z","timestamp":1446550693000},"page":"1-202","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":75,"title":["Collagenase clostridium histolyticum for the treatment of Dupuytren\u2019s contracture: systematic review and economic evaluation"],"prefix":"10.3310","volume":"19","author":[{"given":"Miriam","family":"Brazzelli","sequence":"first","affiliation":[{"name":"Health Services Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Cruickshank","sequence":"additional","affiliation":[{"name":"Health Services Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Tassie","sequence":"additional","affiliation":[{"name":"Health Economics Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"McNamee","sequence":"additional","affiliation":[{"name":"Health Economics Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Robertson","sequence":"additional","affiliation":[{"name":"Health Services Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Elders","sequence":"additional","affiliation":[{"name":"Health Services Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Fraser","sequence":"additional","affiliation":[{"name":"Health Services Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Health Economics Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lawrie","sequence":"additional","affiliation":[{"name":"NHS Grampian, Aberdeen Royal Infirmary, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Ramsay","sequence":"additional","affiliation":[{"name":"Health Services Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2015,10]]},"reference":[{"key":"key20151102152346617_ref1-bib1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/bmj.332.7538.397","article-title":"Dupuytren\u2019s contracture unfolded","volume":"332","author":"Townley","year":"2006","journal-title":"BMJ"},{"key":"key20151102152346617_ref1-bib2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nrrheum.2010.180","article-title":"Scientific understanding and clinical management of Dupuytren disease","volume":"6","author":"Shih","year":"2010","journal-title":"Nature Rev Rheumatol"},{"key":"key20151102152346617_ref1-bib3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1185\/03007995.2013.766163","article-title":"Recognition, diagnosis and referral of patients with Dupuytren\u2019s disease: a review of current concepts for general practitioners in Europe","volume":"29","author":"van Dijk","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"key20151102152346617_ref1-bib4","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jhsa.2013.03.036","article-title":"The impact of dupuytren disease on patient activity and quality of life","volume":"38","author":"Wilburn","year":"2013","journal-title":"J Hand Surg"},{"key":"key20151102152346617_ref1-bib5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2106\/00004623-195941040-00008","article-title":"Dupuytren\u2019s contracture; a new concept of the pathogenesis correlated with surgical management","volume":"41","author":"Luck","year":"1959","journal-title":"J Bone Joint Surg Am"},{"key":"key20151102152346617_ref1-bib6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-2474-12-73","article-title":"Dupuytren\u2019s contracture: a retrospective database analysis to assess clinical management and costs in England","volume":"12","author":"Gerber","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"key20151102152346617_ref1-bib7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.hcl.2013.08.016","article-title":"Collagenase injections for treatment of Dupuytren disease","volume":"30","author":"Hentz","year":"2014","journal-title":"Hand Clin"},{"key":"key20151102152346617_ref1-bib8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1308\/003588406X83104","article-title":"Management of Dupuytren\u2019s disease \u2013 clear advice for an elusive condition","volume":"88","author":"Bayat","year":"2006","journal-title":"Ann R Coll Surg Engl"},{"key":"key20151102152346617_ref1-bib9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2106\/00004623-200701000-00026","article-title":"Dupuytren disease: anatomy, pathology, presentation, and treatment","volume":"89","author":"Rayan","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"key20151102152346617_ref1-bib10","article-title":"Surgical complications associated with fasciectomy for Dupuytren\u2019s disease: a 20-year review of the English literature","volume":"10","author":"Denkler","year":"2010","journal-title":"Eplasty"},{"key":"key20151102152346617_ref1-bib11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.12968\/hmed.2012.73.8.432","article-title":"Clostridium histolyticum collagenase in the treatment of Dupuytren\u2019s contracture","volume":"73","author":"Azzopardi","year":"2012","journal-title":"Br J Hosp Med"},{"key":"key20151102152346617_ref1-bib12","volume-title":"Assessment Report: Xiapex Procedure No. EMEA\/H\/C\/2048","author":"European Medicines Agency","year":"2011"},{"key":"key20151102152346617_ref1-bib13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJMoa1101029","article-title":"Wnt signaling and Dupuytren\u2019s disease","volume":"365","author":"Dolmans","year":"2011","journal-title":"N Engl J Med"},{"key":"key20151102152346617_ref1-bib14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(03)13871-8","article-title":"Guillaume Dupuytren and finger contractures","volume":"362","author":"Gudmundsson","year":"2003","journal-title":"Lancet"},{"key":"key20151102152346617_ref1-bib15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1399-0004.2005.00504.x","article-title":"Mapping of an autosomal dominant gene for Dupuytren\u2019s contracture to chromosome 16q in a Swedish family","volume":"68","author":"Hu","year":"2005","journal-title":"Clin Genet"},{"key":"key20151102152346617_ref1-bib16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.surge.2012.01.004","article-title":"Advances in the understanding of the aetiology of Dupuytren\u2019s disease","volume":"10","author":"Picardo","year":"2012","journal-title":"Surgeon"},{"key":"key20151102152346617_ref1-bib17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s11552-013-9597-3","article-title":"Psychometric properties of health-related quality of life instruments in patients undergoing palmar fasciectomy for dupuytren\u2019s disease: a prospective study","volume":"9","author":"Thoma","year":"2014","journal-title":"Hand"},{"key":"key20151102152346617_ref1-bib18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/oemed-2011-100319","article-title":"Heavy manual work, exposure to vibration and Dupuytren\u2019s disease? Results of a surveillance program for musculoskeletal disorders","volume":"69","author":"Descatha","year":"2012","journal-title":"Occup Environ Med"},{"key":"key20151102152346617_ref1-bib19","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jclinepi.2003.11.015","article-title":"A prospective study linked both alcohol and tobacco to Dupuytren\u2019s disease","volume":"57","author":"Godtfredsen","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"key20151102152346617_ref1-bib20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/01.prs.0000278455.63546.03","article-title":"Dupuytren\u2019s disease: history, diagnosis, and treatment","volume":"120","author":"Shaw","year":"2007","journal-title":"Plast Reconst Surg"},{"key":"key20151102152346617_ref1-bib21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00006534-197407000-00004","article-title":"Patterns of the diseased fascia in the fingers in Dupuytren\u2019s contracture. Displacement of the neurovascular bundle","volume":"54","author":"McFarlane","year":"1974","journal-title":"Plast Reconstr Surg"},{"key":"key20151102152346617_ref1-bib22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s11552-008-9160-9","article-title":"Epidemiological evaluation of Dupuytren\u2019s disease incidence and prevalence rates in relation to etiology","volume":"4","author":"Hindocha","year":"2009","journal-title":"Hand"},{"key":"key20151102152346617_ref1-bib23","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1302\/0301-620X.44B3.602","article-title":"Population studies in Dupuytren\u2019s contracture","volume":"44","author":"Early","year":"1962","journal-title":"J Bone Joint Surg"},{"key":"key20151102152346617_ref1-bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0749-0712(21)00440-6","article-title":"Genetics of Dupuytren\u2019s disease","volume":"15","author":"Burge","year":"1999","journal-title":"Hand Clin"},{"key":"key20151102152346617_ref1-bib25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/0266-7681(93)90124-X","article-title":"A study of the repeatability of the diagnosis of Dupuytren\u2019s contracture and its prevalence in the grampian region","volume":"18","author":"Lennox","year":"1993","journal-title":"J Hand Surg Br"},{"key":"key20151102152346617_ref1-bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0749-0712(21)00439-X","article-title":"Epidemiology of Dupuytren\u2019s disease","volume":"15","author":"Ross","year":"1999","journal-title":"Hand Clin"},{"key":"key20151102152346617_ref1-bib27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11552-007-9076-9","article-title":"Gender ratio of Dupuytren\u2019s disease in the modern U.S. population","volume":"3","author":"Anthony","year":"2008","journal-title":"Hand"},{"key":"key20151102152346617_ref1-bib28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0072-968X(76)90013-9","article-title":"Dupuytren\u2019s disease \u2013 a study of the pattern of distribution and stage of contracture of the hand","volume":"8","author":"Mikkelsen","year":"1976","journal-title":"Hand"},{"key":"key20151102152346617_ref1-bib29","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jhsb.2006.05.005","article-title":"Dupuytren\u2019s contracture: an audit of the outcomes of surgery","volume":"31","author":"Dias","year":"2006","journal-title":"J Hand Surg"},{"key":"key20151102152346617_ref1-bib30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1471-2474-8-60","article-title":"50 years experience with Dupuytren\u2019s contracture in the Erlangen University Hospital \u2013 a retrospective analysis of 2919 operated hands from 1956 to 2006","volume":"8","author":"Loos","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"key":"key20151102152346617_ref1-bib31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1054\/jhsb.2002.0776","article-title":"Functional benefit of Dupuytren\u2019s surgery","volume":"27","author":"Sinha","year":"2002","journal-title":"J Hand Surg Br"},{"key":"key20151102152346617_ref1-bib32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.12968\/hmed.2007.68.11.27683","article-title":"Assessment of clinical severity in Dupuytren\u2019s disease","volume":"68","author":"Bayat","year":"2007","journal-title":"Br J Hosp Med"},{"key":"key20151102152346617_ref1-bib33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jht.2008.08.003","article-title":"Evaluation of activity limitation and digital extension in Dupuytren\u2019s contracture three months after fasciectomy and hand therapy interventions","volume":"22","author":"Engstrand","year":"2009","journal-title":"J Hand Ther"},{"key":"key20151102152346617_ref1-bib34","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/1753193410397971","article-title":"The efficacy and safety of fasciectomy and fasciotomy for Dupuytren\u2019s contracture in European patients: a structured review of published studies","volume":"36","author":"Crean","year":"2011","journal-title":"J Hand Surg Eur"},{"key":"key20151102152346617_ref1-bib35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1177\/1753193410376286","article-title":"The outcome of surgical treatments for primary Dupuytren\u2019s disease \u2013 a systematic review","volume":"35","author":"Becker","year":"2010","journal-title":"J Hand Surg Eur"},{"key":"key20151102152346617_ref1-bib36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bjps.2012.08.019","article-title":"The consequences of different definitions for recurrence of Dupuytren\u2019s disease","volume":"66","author":"Kan","year":"2013","journal-title":"J Plast Reconstruct Aesthetic Surg"},{"key":"key20151102152346617_ref1-bib37","volume-title":"BSSH Evidence for Surgical Treatment 1 Dupuytren\u2019s Disease","author":"British Society for Surgery of the Hand (BSSH)","year":"2010"},{"key":"key20151102152346617_ref1-bib38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.hcl.2013.09.005","article-title":"Needle aponeurotomy for the treatment of dupuytren\u2019s disease","volume":"30","author":"Diaz","year":"2014","journal-title":"Hand Clin"},{"key":"key20151102152346617_ref1-bib39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0749-0712(21)00900-8","article-title":"Diagnosis and indications for surgical treatment","volume":"7","author":"Smith","year":"1991","journal-title":"Hand Clin"},{"key":"key20151102152346617_ref1-bib40","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0072-968X(82)80053-3","article-title":"The table top test","volume":"14","author":"Hueston","year":"1982","journal-title":"Hand"},{"key":"key20151102152346617_ref1-bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0749-0712(21)00443-1","article-title":"Nonoperative treatment of Dupuytren\u2019s disease","volume":"15","author":"Hurst","year":"1999","journal-title":"Hand Clin"},{"key":"key20151102152346617_ref1-bib42","volume-title":"Radiation Therapy for Early Dupuytren\u2019s Disease IPG368","author":"National Institute for Health and Clinical Excellence","year":"2010"},{"key":"key20151102152346617_ref1-bib43","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/ijcp.12099","article-title":"Dupuytren\u2019s disease presentation, referral pathways and resource utilisation in Europe: regional analysis of a surgeon survey and patient chart review","volume":"67","author":"Dahlin","year":"2013","journal-title":"Int J Clin Pract"},{"key":"key20151102152346617_ref1-bib44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/ijcp.12106","article-title":"Surgical management of Dupuytren\u2019s contracture in Europe: regional analysis of a surgeon survey and patient chart review","volume":"67","author":"Dias","year":"2013","journal-title":"Int J Clin Pract"},{"key":"key20151102152346617_ref1-bib45","volume-title":"Needle Fasciotomy for Dupuytren\u2019s Contracture IPG43","author":"National Institute for Clinical Excellence","year":"2004"},{"key":"key20151102152346617_ref1-bib46","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1021\/bi00377a004","article-title":"Limited proteolysis of type I collagen at hyperreactive sites by class I and II Clostridium histolyticum collagenases: complementary digestion patterns","volume":"26","author":"French","year":"1987","journal-title":"Biochemistry (Mosc)"},{"key":"key20151102152346617_ref1-bib47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2147\/TCRM.S8591","article-title":"The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease","volume":"6","author":"Thomas","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"key20151102152346617_ref1-bib48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/jhsu.2000.6918","article-title":"Enzyme injection as nonsurgical treatment of Dupuytren\u2019s disease","volume":"25","author":"Badalamente","year":"2000","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib49","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0753-9053(05)80273-X","article-title":"A mid-term review of the results of dermofasciectomy for Dupuytren\u2019s disease","volume":"11","author":"Searle","year":"1992","journal-title":"Ann Chir Main Memb Super"},{"key":"key20151102152346617_ref1-bib50","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/00006534-196106000-00001","article-title":"Limited fasciectomy for Dupuytren\u2019s contracture","volume":"27","author":"Hueston","year":"1961","journal-title":"Plast Reconstr Surg Transplant Bull"},{"key":"key20151102152346617_ref1-bib51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0266-7681(97)80061-7","article-title":"Skin replacement in Dupuytren\u2019s disease","volume":"22","author":"Hall","year":"1997","journal-title":"J Hand Surg Br"},{"key":"key20151102152346617_ref1-bib52","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0266-7681(84)80019-4","article-title":"Assessment of percutaneous fasciotomy in the management of Dupuytren\u2019s contracture","volume":"9","author":"Rowley","year":"1984","journal-title":"J Hand Surg Br"},{"key":"key20151102152346617_ref1-bib53","volume-title":"Hospital Episode Statistics, Admitted Patient Care \u2013 England, 2012\u201313 Diagnosis","author":"Health and Social Care Information Centre","year":"2013"},{"key":"key20151102152346617_ref1-bib54","volume-title":"A Simple Guide to Payment by Results","author":"Department of Health","year":"2012"},{"key":"key20151102152346617_ref1-bib55","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"key":"key20151102152346617_ref1-bib56","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/j.jhsa.2010.08.007","article-title":"Injectable collagenase clostridium histolyticum: a new nonsurgical treatment for Dupuytren\u2019s disease","volume":"35","author":"Gilpin","year":"2010","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib57","first-page":"545","article-title":"Dupuytren contracture: comparative study between parcial fasciotomy and percutaneous fasciotomy","volume":"48","author":"Ribak","year":"2013","journal-title":"Braz J Orthop"},{"key":"key20151102152346617_ref1-bib58","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"Higgins","year":"2011"},{"key":"key20151102152346617_ref1-bib59","volume-title":"Systematic Reviews: CRD\u2019s Guidance for Undertaking Systematic Reviews in Health Care","author":"Centre for Reviews and Dissemination","year":"2009"},{"key":"key20151102152346617_ref1-bib60","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"J Epidemiol Community Health"},{"key":"key20151102152346617_ref1-bib61","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/S0895-4356(98)00131-0","article-title":"The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus","volume":"51","author":"Verhagen","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"key20151102152346617_ref1-bib62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/ebm.11.2.35","article-title":"The GATE frame: critical appraisal with pictures","volume":"11","author":"Jackson","year":"2006","journal-title":"Evid Based Med"},{"key":"key20151102152346617_ref1-bib63","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.2310\/6650.2005.00205.41","article-title":"Nonsurgical treatment of Dupuytren\u2019s disease","volume":"53","author":"Badalamente","year":"2005","journal-title":"J Investig Med"},{"key":"key20151102152346617_ref1-bib64","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1053\/jhsu.2002.35299","article-title":"Collagen as a clinical target: nonoperative treatment of Dupuytren\u2019s disease","volume":"27","author":"Badalamente","year":"2002","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib65","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jhsa.2007.04.002","article-title":"Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren\u2019s contracture","volume":"32","author":"Badalamente","year":"2007","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib66","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/BF03256918","article-title":"Determining clinically important changes in range of motion in patients with Dupuytren\u2019s Contracture: secondary analysis of the randomized, double-blind, placebo-controlled CORD I study","volume":"31","author":"Witthaut","year":"2011","journal-title":"Clin Drug Invest"},{"key":"key20151102152346617_ref1-bib67","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhsb.2005.07.001","article-title":"Recurrence after surgery for Dupuytren\u2019s disease: a randomized trial of two skin incisions","volume":"30","author":"Citron","year":"2005","journal-title":"J Hand Surg Br"},{"key":"key20151102152346617_ref1-bib68","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1302\/0301-620X.91B3.21054","article-title":"Does a \u2018firebreak\u2019 full-thickness skin graft prevent recurrence after surgery for Dupuytren\u2019s contracture?: a prospective, randomised trial","volume":"91","author":"Ullah","year":"2009","journal-title":"J Bone Joint Surg Br"},{"key":"key20151102152346617_ref1-bib69","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jhsa.2006.02.021","article-title":"A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren\u2019s disease: a 6-week follow-up study","volume":"31","author":"van Rijssen","year":"2006","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib70","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/PRS.0b013e31823aea95","article-title":"Five-year results of a randomized clinical trial on treatment in Dupuytren\u2019s disease: percutaneous needle fasciotomy versus limited fasciectomy","volume":"129","author":"van Rijssen","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"key20151102152346617_ref1-bib71","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11552-013-9540-7","article-title":"Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren\u2019s contracture","volume":"8","author":"Naam","year":"2013","journal-title":"Hand"},{"key":"key20151102152346617_ref1-bib72","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1016\/j.jhsa.2013.08.096","article-title":"A comparison of percutaneous needle fasciotomy and collagenase injection for Dupuytren disease","volume":"38","author":"Nydick","year":"2013","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12570-012-0092-z","article-title":"Current trends in the surgical management of Dupuytren\u2019s disease in Europe: an analysis of patient charts","volume":"3","author":"Bainbridge","year":"2012","journal-title":"Eur Orthop Traumatol"},{"key":"key20151102152346617_ref1-bib74","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0266-7681(03)00221-3","article-title":"Skin tension in the aetiology of Dupuytren\u2019s disease; a prospective trial","volume":"28","author":"Citron","year":"2003","journal-title":"J Hand Surg Br"},{"key":"key20151102152346617_ref1-bib75","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/01.PRS.0000101054.80392.88","article-title":"The surgical treatment of Dupuytren\u2019s contracture: a synthesis of techniques","volume":"113","author":"Skoff","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"key20151102152346617_ref1-bib76","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/ans.12513","article-title":"Dupuytren\u2019s contracture: an analysis of outcomes of percutaneous needle fasciotomy versus open fasciectomy [published online ahead of print ]","volume":"85","author":"Toppi","year":"2015","journal-title":"ANZ J Surg"},{"key":"key20151102152346617_ref1-bib77","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0363-5023(11)60018-X","article-title":"Longer-term follow-up of recurrence after collagenase injection for dupuytren\u2019s contracture level 1 evidence","volume":"36","author":"Badalamente","year":"2011","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib78","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2474-13-61","article-title":"Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren\u2019s cords: an exploratory study","volume":"13","author":"Coleman","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"key20151102152346617_ref1-bib79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jhsa.2013.10.002","article-title":"Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures","volume":"39","author":"Coleman","year":"2014","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib80","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1007\/s11845-014-1111-6","article-title":"Early results of the use of collagenase in the treatment of Dupuytren\u2019s contracture","volume":"182","author":"Considine","year":"2013","journal-title":"Ir J Med Sci"},{"key":"key20151102152346617_ref1-bib81","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s40261-013-0139-0","article-title":"Isolated and spontaneous correction of proximal interphalangeal joint contractures in Dupuytren\u2019s disease: an exploratory analysis of the efficacy and safety of collagenase clostridium histolyticum","volume":"33","author":"Hayton","year":"2013","journal-title":"Clin Drug Invest"},{"key":"key20151102152346617_ref1-bib82","doi-asserted-by":"publisher","first-page":"08","DOI":"10.1016\/S0363-5023(12)60019-7","article-title":"Patterns of recurrent contracture in patients with Dupuytren\u2019s disease 3 years following successful treatment with collagenase clostridium histolyticum: Level 4 evidence","volume":"37","author":"Kaplan","year":"2012","journal-title":"J Hand Surg"},{"key":"key20151102152346617_ref1-bib83","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/j.jhsa.2013.08.084","article-title":"Delayed manipulation following clostridial collagenase histolyticum injection for dupuytren contracture","volume":"38","author":"Kaplan","year":"2013","journal-title":"J Hand Surg"},{"key":"key20151102152346617_ref1-bib84","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.recot.2013.07.005","article-title":"Treatment of Dupuytren\u2019s disease using collagenase from Clostridium histolyticum","volume":"57","author":"Martin-Ferrero","year":"2013","journal-title":"Rev Esp Cirug Ortop Traumatol"},{"key":"key20151102152346617_ref1-bib85","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11552-013-9524-7","article-title":"Examining the efficacy and maintenance of contracture correction after collagenase clostridium histolyticum treatment for Dupuytren\u2019s disease","volume":"8","author":"McMahon","year":"2013","journal-title":"Hand"},{"key":"key20151102152346617_ref1-bib86","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.jhsa.2013.08.114","article-title":"Collagenase clostridium histolyticum for dupuytren-contracture: patterns of use and effectiveness in clinical practice","volume":"38","author":"Peimer","year":"2013","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib87","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jhsa.2012.09.028","article-title":"Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data","volume":"38","author":"Peimer","year":"2013","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib88","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jhsa.2013.01.038","article-title":"The effect of a therapy protocol for increasing correction of severely contracted proximal interphalangeal joints caused by dupuytren disease and treated with collagenase injection","volume":"38","author":"Skirven","year":"2013","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib89","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jhsa.2010.01.003","article-title":"Collagenase injection as nonsurgical treatment of Dupuytren\u2019s disease: 8-year follow-up","volume":"35","author":"Watt","year":"2010","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib90","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jhsa.2012.10.008","article-title":"Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies","volume":"38","author":"Witthaut","year":"2013","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib91","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12570-013-0237-8","article-title":"Clinical efficacy and cost-effectiveness of Clostridium histolyticum collagenase injections in a subpopulation of Dupuytren\u2019s contracture patients","volume":"5","author":"Syed","year":"2013","journal-title":"Eur Orthop Traumatol"},{"key":"key20151102152346617_ref1-bib92","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/2000656X.2012.683795","article-title":"Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren\u2019s contracture","volume":"46","author":"Bainbridge","year":"2012","journal-title":"J Plast Surg Hand Surg"},{"key":"key20151102152346617_ref1-bib93","first-page":"775","article-title":"Our experience with 186 operated Dupuytren hands. Comparison of two techniques","volume":"48","author":"Matton","year":"1982","journal-title":"Acta Orthop Belg"},{"key":"key20151102152346617_ref1-bib94","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1097\/PRS.0b013e3181f83129","article-title":"An evidence-based approach to Dupuytren\u2019s contracture","volume":"126","author":"Brandt","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"key20151102152346617_ref1-bib95","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jhsb.2004.02.002","article-title":"Severe contracture of the proximal interphalangeal joint in Dupuytren\u2019s disease: does capsuloligamentous release improve outcome?","volume":"29","author":"Beyermann","year":"2004","journal-title":"J Hand Surg Br"},{"key":"key20151102152346617_ref1-bib96","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/jhsu.2000.jhsu25a0291","article-title":"Results following surgery for recurrent Dupuytren\u2019s disease","volume":"25","author":"Roush","year":"2000","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib97","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0007-1226(84)90036-5","article-title":"Fasciotomy and Z-plasty in the management of Dupuytren\u2019s contracture","volume":"37","author":"Watson","year":"1984","journal-title":"Br J Plast Surg"},{"key":"key20151102152346617_ref1-bib98","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s11552-011-9326-8","article-title":"A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren\u2019s contracture","volume":"6","author":"Chen","year":"2011","journal-title":"Hand"},{"key":"key20151102152346617_ref1-bib99","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11552-011-9355-3","article-title":"Percutaneous fasciotomy for the treatment of Dupuytren\u2019s disease-a systematic review","volume":"6","author":"Salhi","year":"2011","journal-title":"Hand"},{"key":"key20151102152346617_ref1-bib100","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.jhsa.2011.08.004","article-title":"Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for dupuytren contracture","volume":"36","author":"Chen","year":"2011","journal-title":"J Hand Surg Am"},{"key":"key20151102152346617_ref1-bib101","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1302\/0301-620X.95B8.31822","article-title":"Cost-effectiveness in the management of Dupuytren\u2019s contracture. A Canadian cost\u2013utility analysis of current and future management strategies","volume":"95","author":"Baltzer","year":"2013","journal-title":"Bone Joint J"},{"key":"key20151102152346617_ref1-bib102","volume-title":"Guide to the Methods of Technology Appraisal","author":"National Institute for Health and Care Excellence (NICE)","year":"2013"},{"key":"key20151102152346617_ref1-bib103","volume-title":"Interim Life Tables, England and Wales, 2010\u20132012","author":"Office for National Statistics (ONS)","year":"2013"},{"key":"key20151102152346617_ref1-bib104","volume-title":"NHS Reference Costs 2012\u201313","author":"Department of Health","year":"2013"},{"key":"key20151102152346617_ref1-bib105","volume-title":"Unit Costs of Health and Social Care 2013","author":"Curtis","year":"2013"},{"key":"key20151102152346617_ref1-bib106","volume-title":"British National Formulary","author":"British Medical Association (BMA) and Royal Pharmaceutical Society of Great Britain (RPS)","year":"2013"},{"key":"key20151102152346617_ref1-bib107","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3109\/17453674.2013.865097","article-title":"Eliciting health state utilities for Dupuytren\u2019s contracture using a discrete choice experiment","volume":"84","author":"Gu","year":"2013","journal-title":"Acta Orthopaedica"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta19900\/hta19900.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002366","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta19900\/hta19900.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002776","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:48:06Z","timestamp":1692114486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta19900\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":107,"journal-issue":{"issue":"90","published-online":{"date-parts":[[2015,10]]}},"alternative-id":["10.3310\/hta19900"],"URL":"https:\/\/doi.org\/10.3310\/hta19900","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}